Pamir Ozan's Form 4 filing
Niagen Bioscience, Inc. (NAGE) · filed Nov 25, 2024
- Accession no.
- 0001628280-24-049079
- Filed
- Nov 25, 2024
- Trade date
- Nov 22, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $21.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pamir OzanCIK 0001834681 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +2,907.2 | $7.36 | +$21,396.99 | 2,907.2 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.